We are live on ! Find out more
IBIO icon

iBio
IBIO

16 hedge funds and large institutions have $329K invested in iBio in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

67% more capital invested

Capital invested by funds: $197K → $329K (+$132K)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

33% more funds holding

Funds holding: 12 → 16 (+4)

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

Holders
16
Holders Change
+4
Holders Change %
+33.33%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$194K
2
Citadel Advisors
Citadel Advisors
Florida
+$32K
3
UBS Group
UBS Group
Switzerland
+$24.4K
4
VF
Virtu Financial
New York
+$15.7K
5
Creative Planning
Creative Planning
Kansas
+$9.36K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$22K
2
WS
Wedbush Securities
California
-$21K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$12.3K
4
Morgan Stanley
Morgan Stanley
New York
-$136

IBIO Hedge Fund Activity: Q4 2019 in Review

16 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q4 2019, worth a combined $329K — up 67% from $197K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new IBIO positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, adding an estimated $194K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $22K sold.

  • 16 institutional investors held iBio (IBIO) as of Q4 2019, up from 12 in Q3 2019.
  • Funds reported $329K of iBio stock for Q4 2019, up 67% quarter-over-quarter.
  • 6 funds opened new iBio positions in Q4 2019 and 2 closed out, a net change of +4 holders.
  • The largest iBio buyer in Q4 2019 was BlackRock, an estimated $194K added.
  • The largest iBio seller in Q4 2019 was Renaissance Technologies, an estimated $22K sold.

Based on aggregated 13F filings for Q4 2019.